Business Weekly

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  عرض المزيد

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  عرض المزيد

From The Office and Succession to The Apprentice and Dragons' Den, does the portrayal of business on television inspire or is it a total turn off to budding entrepreneurs? And how challenging is it to create great drama from the world of business? Is 'greed, for lack of a better ...  عرض المزيد

We are reading the headlines about layoffs that have started across corporate America. Twitter made headlines this week. But then anything involving Elon is making headlines these days. Even Facebook parent Meta is expected to lay off thousands after hiring nearly 42,000 emplo ...

**FIRST EPISODE - WEDNESDAY 30TH AUGUST** Does money really make the world go round? Economics, business and finance have long been subjects we leave to the stock brokers, hedge fund managers and business school professors who spend their lives obsessing over them - but there’s ...  عرض المزيد

This week on Prof G Markets, Scott explains why Goldman Sachs is refocusing on its asset management business and scaling back its efforts in consumer banking. He then shares his thoughts on why catering to the 1% continues to be a lucrative business model, even as it sows inequal ...  عرض المزيد